Employment decrease among patients newly diagnosed with early versus late-stage cancers in the us

The total economic burden of cancer reflects direct and indirect costs, including productivity loss due to employment change, absenteeism, presenteeism, and premature death of patients and impacts on caregivers. This study estimated the magnitude of employment decrease among employees newly diagnosed with early (non-metastatic) versus late-stage (metastatic) cancer in the US.